Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:37 PM
Ignite Modification Date: 2025-12-25 @ 12:11 PM
NCT ID: NCT00344461
Description: A written report will be filed with the Institutional Review Board (IRB) within 5 working days for serious adverse event and annually for all others.
Frequency Threshold: 0
Time Frame: 96 weeks
Study: NCT00344461
Study Brief: A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
FTC, TDF, & NVP To evaluate the long-term antiviral activity of a three cell cycle independent reverse transcriptase regimen consisting of Nevirapine 200mg twice-a-day, Tenofovir 300mg and Emtricitabine 200mg once-a-day in the treatment of patients with chronic HIV infection. 1 None 16 54 13 54 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Neutrapenia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Grade 3 & 4 Liver Function Test NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders None View
Pneumonia NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Grade 4 alanine aminotransferase (ALT) test NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders None View
Rash NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
CMV Retinitis NON_SYSTEMATIC_ASSESSMENT Eye disorders None View
Aortic Aneurysm NON_SYSTEMATIC_ASSESSMENT Vascular disorders None View
Diffused Lung Disease NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Right Femoral Deep Vein Thrombosis NON_SYSTEMATIC_ASSESSMENT Vascular disorders None View
Hepatotoxicity NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders None View
Sepsis NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Malignant Lymphoma NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Syncopy NON_SYSTEMATIC_ASSESSMENT General disorders None View
Depression NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders None View
Sinusitis NON_SYSTEMATIC_ASSESSMENT General disorders None View
Drug Detoxicity NON_SYSTEMATIC_ASSESSMENT General disorders None View
Bronchitis NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Herpes Zoster Othalmicus NON_SYSTEMATIC_ASSESSMENT Eye disorders None View
Left Hand Trauma NON_SYSTEMATIC_ASSESSMENT General disorders None View
Stabbing NON_SYSTEMATIC_ASSESSMENT General disorders None View
Viral Gastroenteritis NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Preseptal Cellulitis NON_SYSTEMATIC_ASSESSMENT Eye disorders None View
Viral Syndrome NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View
Abscess Right Leg NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View